Oliver and colleagues in fact concluded that IL17RC hypomethylation in peripheral blood was not a suitable clinical biomarker of AMD, highlighting the need for considerable replication of epigenetic association studies prior to clinical application [18]. The gene discussed is IL17RC; the disease is age-related macular degeneration.